Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Cumberland Pharmaceuticals Inc. (CPIX)

BGM Group Ltd. and Cumberland Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. is the larger, with a market value of $125.7M against $75.1M — 1.7× the size. Cumberland Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 148×. BGM Group Ltd. has the higher net margin (1.96% vs −34.9%) and the higher return on invested capital (0.00% vs −34.2%). Across the 15 metrics below, BGM Group Ltd. leads on 8 and Cumberland Pharmaceuticals Inc. on 7.

Valuation

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
P/E 148.17 n/m 20.55
P/S n/m 2.41 2.08
P/B n/m 4.41 1.79
Price to free cash flow n/m 131.12 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales (0.09) 2.62 2.87
Earnings yield 0.67% (14.48%) (15.94%)
Free cash flow yield 0.00% 0.76% 0.00%

Profitability

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 110.49% 53.51%
Operating margin 0.00% (23.20%) 0.00%
Net margin 1.96% (34.92%) (2.45%)
Free cash flow margin 0.00% 1.84% 0.00%
Return on equity 0.00% (48.76%) (0.80%)
Return on assets 0.00% (16.70%) (1.67%)
Return on invested capital 0.00% (34.23%) 0.00%

Growth

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (25.68%) 5.22%
EPS growth (last fiscal year) 10.00% 58.70% 42.91%
Revenue growth, 5-year CAGR (5.39%) 3.52% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 1.25 0.96 2.41
Net debt to EBITDA 0.97 (4.58) 1.01

Dividend

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.45%
Payout ratio — — 0.27

Size

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Market cap 125.72m 75.06m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack